Cargando…

OR30-3 Structural Basis of Activation and Sustained Signaling by the PTH Receptor

Parathyroid hormone (PTH) receptor (PTHR) is a medically important family B G Protein Coupled Receptor (GPCR) that primarily couples to Gs/cAMP and Gq/Ca(2+) signaling pathways and has a central role in regulating Ca(2+) homeostasis and bone turnover. PTHR is activated by two endogenous hormones, en...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sutkeviciute, Ieva, Zhao, Li-Hua, Zhang, Yan, Xu, H Eric, Vilardaga, Jean-Pierre
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2019
Materias:	Bone and Mineral Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554852/ http://dx.doi.org/10.1210/js.2019-OR30-3

Ejemplares similares

MON-538 Ca(2+)Allostery in PTH-Receptor Signaling
por: White, Alex, et al.
Publicado: (2019)

OR21-3 Spatial Signaling Bias of a Gain-of-Function PTH1R Mutant Associated with Delayed Ossification in Eiken Syndrome
por: Dean, Thomas, et al.
Publicado: (2022)

OR23-01 The Nonredundant Role Of Beta-Amyloid In Mediating Tonic PTH Secretion In Physiological And Pathological States
por: Tu, Chia-Ling, et al.
Publicado: (2023)

OR07-01 Identification of the First Case of Acquired Autoimmune Parathyroid Hormone (PTH) Resistance Due to PTH1 Receptor (PTH1R) Autoantibodies
por: Mandl, Adel, et al.
Publicado: (2020)

Improving the Accuracy and Reliability of Parathyroid Hormone Levels Through the Mass-Spectrometric Measurement of Full-length PTH and C-Terminal PTH Fragments
por: Ulmer, Candice Z, et al.
Publicado: (2021)

SAT-LB72 Design of the PaTH Forward Phase 2 Trial of TransCon PTH, a Long-Acting PTH, in Patients With Hypoparathyroidism
por: Khan, Aliya Aziz, et al.
Publicado: (2020)

Ectopic Intact PTH Secretion Causing Humoral Hypercalcemia of Malignancy
por: Rauf, Mohammad Talha, et al.
Publicado: (2021)

PTH Protects Osteocytes From Oxidative Stress and Cellular Senescence
por: Uda, Yuhei, et al.
Publicado: (2021)

PSAT158 Dimeric [Cys25]PTH(1-34) and Monomeric PTH(1-34) Differentially Regulate the Expression of Genes Related to Calcium Homeostasis in Bone and Kidney
por: Lee, Sihoon, et al.
Publicado: (2022)

MON-343 The Mystery of Recurrent PTH-Independent Hypercalcemia with Severe Hypophosphatemia
por: Shaikh, Bilal, et al.
Publicado: (2020)

A Curious Case of PTH Independent Hypercalcemia Secondary to Silicone Injections
por: Matos, Moises, et al.
Publicado: (2021)

SAT-402 Investigating Analogues of Parathyroid Hormone (PTH) and PTH-Related Peptide (PTHrP) to Improve Anabolic: Catabolic Response Ratios Using UMR106-01 Osteocytic Cells
por: Oladapo, Oladipo Posi, et al.
Publicado: (2020)

Rare Case of Severe Hypocalcemia Due to PTH Resistance Related to Diet Pill
por: Katkar, Rujuta Baban, et al.
Publicado: (2021)

SAT211 PTH-secreting Endometrial Carcinoma: A Rare Cause of Hypercalcemia
por: Fanous, Ereeny, et al.
Publicado: (2023)

ODP118 PTH (1-34) Replacement Therapy for Hypoparathyroidism due to Sporadic Calcium Sensing Receptor Gain-of-Function Point Mutation
por: Basina, Marina, et al.
Publicado: (2022)

MON-534 Reduced PTH Levels in Adolescents with Anorexia Nervosa: Implication for Kidney and Bone
por: Lenherr-Taube, Nina, et al.
Publicado: (2019)

SAT-503 A Rare Case of Hypercalcemia Due to PTH Secreting Lung Adenocarcinoma
por: Gonzalez-Falero, Andrea, et al.
Publicado: (2019)

SAT-396 A Non-Surgical Animal Model of Hypoparathyroidism for Testing PTH Analogues
por: Ramezani-Pour, Narjes, et al.
Publicado: (2020)

SAT-388 Dry Cough as Only Sign of a Parathyroid Adenoma Producer of PTH
por: Selman-Geara, Antonio, et al.
Publicado: (2020)

Treatment-Resistant Hypercalcemia Secondary to Ectopic PTH Hypersecretion From Disseminated Ovarian Cancer
por: Balinski, Alexander M, et al.
Publicado: (2021)

SAT195 A Curious Case Of Severe Reversible PTH-mediated Hypercalcemia Of Pregnancy
por: Albanese, Isabella, et al.
Publicado: (2023)

THU474 Primary Hyperaldosteronism As A Cause Of PTH Elevation After Parathyroid Surgery
por: Thi, Wai Phyo, et al.
Publicado: (2023)

RF30 | PSAT135 Rare Case of Hypercalcemia Mediated by an Ectopic Parathyroid Hormone (PTH), and Parathyroid Hormone-Related Peptide (PTHrP) Co-Secretion Secondary to Metastatic Cervical Carcinoma
por: Gaballa, Salem, et al.
Publicado: (2022)

MON-533 Irisin in Post-Menopausal Women with Primary Hyperparathyroidism: An Interplay between Irisin and Pth
por: Palermo, Andrea, et al.
Publicado: (2019)

OR03-2 Different Effects of Abaloparatide and h-PTH(1-34) on Osteoclastogenesis and Bone Resorption
por: Arlt, Heike, et al.
Publicado: (2019)

SAT-492 Intact PTH Secretion from Hepatocellular Carcinoma in a Patient Presenting with Hypercalcemia
por: Weaver, Anne, et al.
Publicado: (2019)

OR07-03 Continuous Subcutaneous Delivery of RhPTH(1-84) by Pump in Adults with Hypoparathyroidism
por: Bove-Fenderson, Erin, et al.
Publicado: (2020)

SAT237 AZP-3601, A Novel PTH 1 Receptor Agonist, Induces Rapid Reduction And Normalization Of Urinary Calcium In Chronic Hypoparathyroid Patients
por: Figueres, Lucile, et al.
Publicado: (2023)

SAT-494 A Very Rare Case: Hypercalcemia Caused by Ectopic PTH Secretion in Endometrial Cancer
por: Batarseh, Nour, et al.
Publicado: (2019)

Novel Method in Performing PTH Washout for Localizing Parathyroid Adenoma: Case Report & an Institute Experience in Qatar
por: Mohammad Salameh, Obada Khalil, et al.
Publicado: (2021)

OR23-04 Treatment Of Chronic Hypoparathyroidism With Eneboparatide (AZP-3601), A Novel PTH 1 Receptor Agonist: Results From A Phase 2 Trial
por: Kamenicky, Peter, et al.
Publicado: (2023)

SAT182 Effects Of An Orally Bioavailable Nonpeptide Parathyroid Hormone Receptor Type 1 (PTH1R) Antagonist In Rodent Models Of Primary Hyperparathyroidism (PHPT)
por: Antwan, Agnes S, et al.
Publicado: (2023)

MON-535 Relationship between Vitamin D and PTH: The Effect of Obesity and Weight Loss after Bariatric Surgery
por: Salazar, Daniela, et al.
Publicado: (2019)

SAT194 A Rare Case Of Untreated Primary Hyperparathyroidism With Extremely High PTH And Lytic Bone Lesions
por: Shah, Mauli, et al.
Publicado: (2023)

SAT-408 Bioactivity of Long Acting PTH Fusion Molecules Tested in a Novel Non-Surgical Animal Model of Hypoparathyroidism
por: Wilkinson, Ian R, et al.
Publicado: (2020)

OR21-4 Comparison of the Effects of PTH (1-34), PTHrP (1-36) and Abaloparatide (ABL) on the Murine Osteoblast Transcriptome
por: He, Zhiming, et al.
Publicado: (2022)

OR21-1 The PaTH Forward Trial: Efficacy and Safety of TransCon PTH Through Week 84 for Adults With Hypoparathyroidism
por: Ahmed, Intekhab, et al.
Publicado: (2022)

SAT257 Efficacy Of Oral Cinacalcet In Non-PTH Non-Malignant Hypercalcemia From Excess 1,25 Dihydroxyvitamin D
por: Mohan, Sneha, et al.
Publicado: (2023)

A Single Administration of AZP-3601, a Novel, Long-Acting PTH Analog, Induces a Significant and Sustained Calcemic Response: Preliminary Data From a Randomized, Double-Blind, Placebo-Controlled Phase 1 Study
por: Allas, Soraya, et al.
Publicado: (2021)

SAT-386 Inconsistent Bilateral Arm Serum PTH Testing in Recurrent Hyperparathyroidism in a Patient Status-Post Parathyroid Auto-Transplantation
por: Jenkins, Craig, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_d2ueu3nqpt6jh3hs5v4sd5cmhv